LYS20 Antibody

What is LYS20 Antibody and what specific modifications does it detect?

LYS20 antibodies are specifically designed to detect various methylation states of histone H4 at lysine 20 (H4K20). These antibodies can be developed to recognize different methylation states including:

• Monomethylation (H4K20me1): Detected by antibodies like Anti-monomethyl-Histone H4 (Lys20)

• Trimethylation (H4K20me3): Detected by antibodies such as Anti-trimethyl-Histone H4 (Lys20)

Each antibody has been validated for specific applications including Western blotting (WB), immunoprecipitation (IP), chromatin immunoprecipitation (ChIP), and dot blotting (DB), with varying degrees of sensitivity and specificity . These antibodies serve as critical tools in epigenetics research, allowing scientists to investigate the dynamic regulation of chromatin structure and function through histone modifications.

What are the differences between polyclonal and monoclonal LYS20 antibodies?

The choice between polyclonal and monoclonal LYS20 antibodies has significant implications for experimental outcomes:

Polyclonal antibodies like the Anti-trimethyl-Histone H4 (Lys20) Antibody are purified from rabbit serum and recognize multiple epitopes, providing robust signal detection across various applications including IP, WB, DB, and ChIP . In contrast, monoclonal antibodies like clone NL314 offer higher specificity for particular methylation states, with enhanced reproducibility across experiments .

What species reactivity can I expect with LYS20 antibodies?

LYS20 antibodies demonstrate cross-species reactivity that should be considered when designing experiments:

The Anti-trimethyl-Histone H4 (Lys20) Antibody shows reactivity against human (H), mouse (M), and rat (R) H4K20me3, making it versatile for comparative studies across these mammalian models . This cross-reactivity stems from the high conservation of histone H4 sequences across species. When selecting an antibody for your research, confirm the validated species in the antibody documentation, as some antibodies may have broader reactivity than officially validated.

For human-specific studies, antibodies targeting human H4C1(8359) gene products are available . Always validate antibody performance in your specific experimental system, particularly when working with less common model organisms not typically included in standard validation protocols.

What are the recommended storage conditions for LYS20 antibodies?

Proper storage is crucial for maintaining antibody activity:

Most LYS20 antibodies should be stored at 2-8°C and remain stable for approximately 1 year from the date of receipt under these conditions . Some antibody preparations may require storage at -20°C or may be shipped on dry ice .

When working with these antibodies, consider these critical handling recommendations:

• Minimize freeze-thaw cycles as they can degrade antibody quality

• For maximum product recovery, centrifuge the vial prior to removing the cap

• Avoid contamination by using sterile technique when handling

• Consider preparing working aliquots for frequent use to preserve the main stock

The storage buffer composition typically includes stabilizers such as 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide, which helps maintain antibody functionality . Always refer to the specific product documentation for any special storage requirements.

How can I validate the specificity of LYS20 antibody for different methylation states?

Validating antibody specificity for distinct H4K20 methylation states requires multiple complementary approaches:

Peptide Competition Assays:
Conduct competition experiments using synthetic peptides containing specific methylation states. For example, the Anti-monomethyl-Histone H4 (Lys20) Antibody can be validated using the Beadlyte Histone-Peptide Specificity Assay, where dilutions (1:2,000-1:30,000) are incubated with histone H4 peptides containing various modifications conjugated to Luminex microspheres .

Recombinant Protein Testing:
Compare antibody reactivity against recombinant histones with defined methylation states. An effective antibody should detect the target methylation state while showing minimal cross-reactivity with unmethylated histones. For instance, Anti-monomethyl-Histone H4 (Lys20) Antibody has been validated not to detect unmethylated recombinant Histone H3 .

Cellular Models with Known Methylation Profiles:
Use cell lines or model systems with established H4K20 methylation patterns. Acid-extracted histones from HeLa cells at 1:1000-1:2000 dilutions can serve as positive controls for detecting monomethyl histone H4 (Lys20) . Comparing signal intensity across samples with differential expression of methyltransferases (like PR-Set7/SETD8 for H4K20me1) can provide additional validation.

Genetic Validation:
Employ genetic approaches using CRISPR/Cas9 to delete or mutate H4K20 methyltransferases or demethylases, creating cellular systems with altered H4K20 methylation profiles for antibody validation.

What are the optimal conditions for using LYS20 antibodies in ChIP experiments?

Chromatin immunoprecipitation (ChIP) with LYS20 antibodies requires careful optimization:

Chromatin Preparation:

• Use fresh cells/tissues when possible

• Crosslink with 1% formaldehyde for 10 minutes at room temperature

• Sonicate to achieve fragments of 200-500 bp (verify by gel electrophoresis)

Antibody Concentration:
The optimal antibody concentration must be empirically determined, but starting points based on validated protocols include:

• For Anti-trimethyl-Histone H4 (Lys20): Use at concentrations validated for ChIP applications

• Typical antibody amounts range from 2-5 μg per ChIP reaction

Controls to Include:

• Input DNA (typically 5-10% of starting material)

• IgG negative control (matching the host species of the LYS20 antibody)

• Positive control regions (known to be enriched for H4K20 methylation)

• Negative control regions (known to lack H4K20 methylation)

Washing Conditions:

• Low salt wash: 0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCl, 150mM NaCl

• High salt wash: 0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCl, 500mM NaCl

• LiCl wash: 0.25M LiCl, 1% NP-40, 1% deoxycholate, 1mM EDTA, 10mM Tris-HCl

Special Considerations:
When studying H4K20 methylation by ChIP, consider that H4K20me1, H4K20me2, and H4K20me3 may localize to different genomic regions and serve distinct functions. H4K20me3 is often associated with heterochromatin and silenced regions, while H4K20me1 may be enriched at active genes .

How do different LYS20 methylation states correlate with biological functions?

H4K20 methylation has diverse biological roles depending on the methylation state:

The Anti-trimethyl-Histone H4 (Lys20) Antibody has been utilized in numerous studies investigating heterochromatin formation and gene silencing mechanisms . Research has shown H4K20me3 enrichment at silenced genes and repetitive elements, and its dysregulation is observed in various cancers and aging-related conditions.

The monomethylated form (H4K20me1) is emerging as particularly important in cell cycle regulation and DNA replication. The enzyme PR-Set7/SETD8 is responsible for H4K20 monomethylation and has been linked to neural stem cell reactivation , highlighting the importance of this modification in developmental processes.

How can I troubleshoot Western blot experiments using LYS20 antibodies?

Western blot optimization for LYS20 antibodies requires addressing several common challenges:

Problem: Weak or No Signal

• Solution: Optimize antibody concentration. For Anti-trimethyl-Histone H4 (Lys20) Antibody, start with 1:1000-1:2000 dilution .

• Solution: Use acid extraction methods to enrich for histones. Standard protein extraction methods may not efficiently recover histones.

• Solution: Increase protein loading (typically 15-30 μg of acid-extracted histones).

• Solution: Extend primary antibody incubation to overnight at 4°C.

Problem: High Background

• Solution: Increase blocking time/concentration (5% non-fat dry milk or BSA).

• Solution: Add 0.1-0.3% Tween-20 in washing buffer.

• Solution: Pre-absorb antibody with nuclear extract from species unrelated to your sample.

• Solution: For polyclonal antibodies, purify IgG fraction before use.

Problem: Multiple Bands

• Solution: Verify histone integrity by Coomassie staining.

• Solution: Use peptide competition assays to identify specific bands.

• Solution: Include positive controls (e.g., HeLa acid extracts for H4K20me1) .

• Solution: Verify antibody specificity using recombinant histones with defined methylation states.

Recommended Protocol:

• Load 15-30 μg of acid-extracted histones

• Transfer to PVDF membrane (preferred over nitrocellulose for histones)

• Block with 5% BSA in TBST for 1 hour

• Incubate with primary antibody at 1:1000-1:2000 dilution overnight at 4°C

• Wash 3× with TBST

• Incubate with HRP-conjugated secondary antibody for 1 hour

• Wash 3× with TBST

• Develop using ECL detection

What is the role of LYS20 in DNA damage response and repair?

LYS20 plays crucial roles in DNA damage response pathways, particularly at double-strand breaks:

Research has shown that Lys20 is recruited to sites of DNA damage, and its overexpression promotes enhanced recruitment of the INO80 remodeling complex to restore chromatin structure . This function represents a moonlighting role distinct from its metabolic function.

Structure-function studies have identified that:

• The C-terminal region of Lys20 (specifically a tract of 20 amino acids, V399-I418) is critical for its role in DNA damage response but dispensable for its metabolic function

• This region has been termed the "moonlighting domain" of Lys20

• Mutations in this domain impair the DNA repair function without affecting lysine biosynthesis

The histone H4K20 methylation state influences DNA repair pathway choice:

• H4K20me1 (created by PR-Set7/SETD8) is important during replication and is cell-cycle regulated

• H4K20me2 serves as a binding site for 53BP1, directing repair toward non-homologous end joining

• Alterations in H4K20 methylation patterns can impact genome stability and cellular senescence

When studying DNA damage response with LYS20 antibodies, researchers should consider the dynamic nature of these modifications during the damage-repair cycle and use time-course experiments to capture these changes.

How can I design multiplexing experiments using LYS20 antibodies?

Multiplexing approaches allow simultaneous detection of multiple histone modifications:

Compatible Antibody Selection:
Choose antibodies raised in different host species or of different isotypes to enable simultaneous detection. For example, rabbit-derived Anti-trimethyl-Histone H4 (Lys20) Antibody can be paired with mouse-derived antibodies against other modifications.

Bead-Based Multiplexing:
The Beadlyte Histone-Peptide Specificity Assay has been successfully used with Anti-monomethyl-Histone H4 (Lys20) Antibody at dilutions of 1:2,000-1:30,000 . This approach allows simultaneous profiling of multiple histone modifications by conjugating different peptides to uniquely coded microspheres.

Sequential ChIP (Re-ChIP):
To determine co-occurrence of H4K20 methylation with other modifications on the same nucleosomes:

• Perform first ChIP with Anti-trimethyl-Histone H4 (Lys20) Antibody

• Elute chromatin complexes under mild conditions

• Perform second ChIP with antibody against another histone modification

• Analyze enriched regions by qPCR or sequencing

Multi-Color Immunofluorescence:
For cellular localization studies:

• Use spectrally distinct fluorophore-conjugated secondary antibodies

• Consider tyramide signal amplification for low-abundance modifications

• Include proper controls for antibody cross-reactivity

• Use spectral unmixing for closely overlapping signals

Technical Considerations:

• Validate antibody specificity individually before multiplexing

• Confirm absence of cross-reactivity between detection systems

• Include single-plex controls alongside multiplexed samples

• Consider potential epitope masking when targeting closely positioned modifications

How are LYS20 antibodies used in cancer epigenetics research?

H4K20 methylation patterns are frequently altered in cancer, making LYS20 antibodies valuable tools in oncology research:

Multiple studies have employed these antibodies to characterize epigenetic reprogramming in cancer. For example, research on colorectal cancer has revealed that IL-22(+)CD4(+) T cells promote cancer stemness via STAT3 transcription factor activation and subsequent induction of the methyltransferase DOT1L . This process alters histone methylation patterns including H4K20 methylation.

In hematological malignancies, hypermethylation of the alternative AWT1 promoter serves as a highly specific marker for acute myeloid leukemias, even in cases with high expression levels . This finding demonstrates how antibodies against modified histones can help identify cancer-specific epigenetic signatures.

Researchers investigating Epstein-Barr virus-mediated transformation of B cells have used anti-H4K20me3 antibodies to determine that this transformation induces global chromatin changes independent of proliferation acquisition . These studies highlight how viral oncogenesis can reprogram the epigenetic landscape through altered histone modifications.

When designing cancer epigenetics studies using LYS20 antibodies, researchers should:

• Include appropriate normal tissue controls

• Consider tumor heterogeneity by analyzing multiple regions

• Correlate histone modification patterns with clinical outcomes

• Integrate with other epigenetic marks (DNA methylation, other histone modifications)

What is the significance of LYS20 methylation in neurodevelopment and neurological disorders?

H4K20 methylation plays critical roles in neurodevelopment and neurological conditions:

Research has shown that histone lysine methyltransferase PR-Set7/SETD8, which is responsible for H4K20 monomethylation, promotes neural stem cell reactivation . This finding indicates the importance of H4K20 methylation in controlling neural stem cell quiescence and proliferation, with significant implications for brain development and homeostasis.

Studies of the BTBR T+tf/J mouse model of autism have revealed cerebellar oxidative DNA damage and altered DNA methylation patterns that correlate with changes in histone modifications, including H4K20 methylation . These alterations show similarities with human post-mortem cerebellum samples from autism patients, suggesting conserved epigenetic mechanisms in this disorder.

In viral encephalitis, which can lead to severe brain damage, epigenetic alterations including changes to histone modification patterns have been observed . While the specific role of H4K20 methylation in this context remains to be fully elucidated, LYS20 antibodies offer valuable tools for investigating these epigenetic changes.

Increasing evidence suggests that variants of histone lysine methyltransferases, including KMT5A (also known as SET8/PR-Set7), are associated with neurodevelopmental disorders . This association highlights the potential clinical relevance of monitoring H4K20 methylation patterns in neurological conditions.

How can new technological advances enhance LYS20 antibody applications?

Recent technological developments have expanded the utility of LYS20 antibodies:

Single-Cell Epigenomics:
Emerging techniques for single-cell ChIP-seq and CUT&Tag are enhancing our ability to study H4K20 methylation heterogeneity within complex tissues. These approaches can reveal cell type-specific patterns that would be masked in bulk tissue analysis. LYS20 antibodies with high specificity and sensitivity are essential for these applications.

CRISPR-Based Epigenome Editing:
CRISPR-Cas9 systems coupled with histone methyltransferases or demethylases enable targeted manipulation of H4K20 methylation at specific genomic loci. LYS20 antibodies are crucial for validating the efficiency and specificity of these editing approaches through ChIP-qPCR or immunofluorescence.

Deep Learning for Pattern Recognition:
Machine learning approaches are increasingly applied to ChIP-seq data analysis, including those generated using LYS20 antibodies. These computational methods can identify subtle patterns in H4K20 methylation distribution that correlate with gene expression or cellular phenotypes, providing new insights into the regulatory roles of these modifications.

Cryo-Electron Microscopy:
Structural studies using cryo-EM are revealing how chromatin-associated proteins recognize and interact with H4K20 methylation marks. These studies provide mechanistic insights into how these modifications influence chromatin structure and function.

Mass Spectrometry-Based Validation:
Novel mass spectrometry approaches for histone analysis serve as orthogonal validation methods for antibody-based detection. Quantitative MS can precisely measure multiple histone modifications simultaneously, helping to validate antibody specificity and relative abundance measurements.

When incorporating these advanced technologies, researchers should consider how antibody characteristics might influence results and include appropriate controls and validation steps.

What considerations are important when designing experiments to study the dynamics of LYS20 methylation?

Studying the dynamic nature of H4K20 methylation requires specialized experimental approaches:

Cell Cycle Synchronization:
H4K20 methylation states change during the cell cycle. For example, H4K20me1 increases during G2/M phase due to PR-Set7/SETD8 activity. When studying these dynamics:

• Use double thymidine block or nocodazole treatment for cell synchronization

• Collect samples at multiple timepoints after synchronization release

• Validate synchronization efficiency using flow cytometry

• Correlate H4K20 methylation with cell cycle markers

Pulse-Chase Experiments:
To track histone turnover and modification dynamics:

• Use SNAP-tag or inducible histones

• Label existing histones

• Follow modification patterns over time with LYS20 antibodies

• Distinguish old vs. new histones through orthogonal labeling

Inhibitor Studies:
Pharmacological inhibitors of methyltransferases and demethylases allow temporal control over H4K20 methylation:

• Use specific inhibitors of PR-Set7/SETD8 to block H4K20me1

• Monitor methylation changes over time using LYS20 antibodies

• Include washout experiments to study recovery dynamics

• Validate target engagement using orthogonal methods

Live-Cell Imaging:
For real-time visualization of H4K20 methylation changes:

• Use antibody-derived intrabodies with fluorescent tags

• Develop specific reader domains fused to fluorescent proteins

• Monitor dynamics at specific genomic loci using CRISPR-based imaging

• Correlate with other cellular processes through multi-color imaging

When designing these experiments, consider the potential impact of fixation methods on epitope accessibility, the temporal resolution required to capture relevant dynamics, and the need for quantitative rather than qualitative assessments of methylation changes.